Resources - COVID-19 information

Section dedicated to information on pharmacovigilance of medicinal products used to treat and prevent COVID-19 (coronavirus).

The section is divided into two parts: one part relating to links to national and international institutional websites on SARS-CoV-2 (COVID-19) and another part relating to important research documents and initiatives from ISoP members and others.
This page will be regularly updated.

COVID-19 Resources

Here you will find some links to national and international institutional websites and published papers on COVID-19. Stay informed with the latest clinical research and resources.

World Health Organization

Centers for Disease Control and Prevention

National Institute of Health

European Medicines Agency

COVID-19 data sources (Knowledge Portal on Innovation and Access to Medicines)

The Lancet

The New England Journal Of Medicine

Oxford Covid-19 Evidence service

The Royal College of Obstetricians and Gynaecologists (RCOG)

Italian Society of Pharmacology - English COVID-19 section

JAMA Network

International Union of Pharmacology and Clinical Pharmacology (IUPHAR)

NIPH-Live map of COVID-19 evidence

Springer Nature

The International Coalition of Medicines Regulatory Authorities (ICMRA)

Safety Monitoring Using WHO Global Database of Individual Case Safety Reports (ICSRs). Descriptive analysis of spontaneous report from VigiBase

Indian Council of Medical Research updated ethical guidance for biomedical and health research

African Vaccine Regulatory Forum (AVAREF) tools for Processing clinical trial applications by Ethics Committees and National Regulatory Authorities in Africa

Landscape of COVID-19 candidate vaccines/Draft

NZ Pharmacovigilance Centre Project encouraging feedback on COVID-19 Medication Safety Challenges in NZ

The Vaccine Centre & London School of Hygiene & Tropical Medicine

Johns Hopkins University-Coronavirus Resource Center

ISoP Member Papers and initiatives

ISoP colleagues in the North American Chapter of ISoP (NASoP) and the Italian Society of Pharmacology (SIF) are working on proposals to monitor the safety of medicines and vaccines to treat and prevent COVID-19. Here you will find also important research documents and initiatives from ISoP members and others.

Official statement of the section of Clinical Pharmacology of the Italian Society of Pharmacology on the use of ACE- inhibitors or angiotensin receptor blockers in COVID-19 infection with commentary


Official Statement of the section of Clinical Pharmacology of Italian Society of Pharmacology on Non-steroidal anti-inflammatory drugs (NSAIDs) and the increased risk of complications during infections with commentary


Simplified description of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2). Viral lifecycle and drug repurposing strategies

Benefit-Risk evaluation for Remdesivir in COVID-19


The challenging times and opportunities for pharmacovigilance in Africa during the COVID‑19 pandemic

African Chapter of ISoP / Executive Committee

*New ISoP infographic ‘Using Medicines Safely during the COVID-19 pandemic’. This infographic is aimed at patients and caregivers - feel free to display it in hospitals, clinics, pharmacies and any other public spaces appropriate to where medicines are obtained in your country


Posibles terapias para COVID-19: revision narrativa de seguridad I. Cloroquina / hidroxicloroquina y azitromicina

Raquel Herrera Comoglio

The contents of this page are intended for purely informational purposes (the list is not exhaustive).
May 2020